Meeting Prep: Ada - health.tech

Caoimhe Vallely - Profile

• Current role: Head of Partnerships at Kheiron Medical Technologies (AI breast cancer screening)
• Previous: Business Development Manager at Sectra (medical imaging), roles at Philips Healthcare
• Education: Biomedical Science, University College Dublin
• Based in: London, UK
• Domain expertise: AI in radiology, NHS partnerships, medtech partnerships
• Active speaker: RSNA, UKIO conferences

Kheiron Medical Technologies

• AI-powered breast cancer screening and clinical decision support
• Deployed in NHS
• Backed by Temasek, Oxford Nanopore investors
• Partnership with Siemens Healthineers

Note on "health.tech"

• The email domain is health.tech -- this may be a separate entity/platform from Kheiron, or Caoimhe may have moved. The meeting title "Ada-health.tech" suggests a partnership exploration between Ada and an organization operating under the health.tech domain.

Strategic Relevance to Ada

• Breast cancer screening + symptom assessment: Ada could serve as the front door for women presenting with breast-related symptoms, routing to Kheiron's AI screening tools.
• NHS connection: Kheiron has NHS deployments; Ada also has UK/NHS presence. Joint offering could strengthen both.
• Patient Finder angle: Undiagnosed breast cancer is a major condition. If health.tech/Kheiron wants to increase screening uptake, Ada's patient identification capability is directly relevant.

Talking Points

1. Understand the ask: Clarify what health.tech is and what Caoimhe is looking to explore
2. Ada's patient finding capability: 15M+ annual assessments, CE-marked clinical grade
3. Screening pathway: Ada symptom assessment -> flagged for screening -> Kheiron AI reads the mammogram
4. NHS/UK market: Both companies have UK presence -- natural starting point
5. Pharma angle: Breast cancer pharma companies (Roche, AstraZeneca, Pfizer oncology) could fund the patient finding

Commitment Tracker

• No open commitments related to health.tech or Caoimhe Vallely